Boston Scientific disclosed that a cyberattack disrupted parts of its IT systems and order-shipping capabilities, and the company could not immediately provide a timeline for full restoration. The incident was detected the day before the filing and affected global operations tied to processing customer orders. The disclosure adds to a growing list of medtech cybersecurity incidents reported across the sector this year, elevating operational continuity risk for manufacturers supporting hospital device purchasing and delivery. For biotech-adjacent workflows that depend on device availability—especially during clinical study execution—IT continuity and secure logistics have become procurement-critical. Regulatory and customer reporting expectations may increase as more disruptions are tied to cyber events, particularly where downtime affects clinical and post-market commitments.